|
1
|
Assarzadegan N and Montgomery E: What is
New in the 2019 World Health Organization (WHO) classification of
tumors of the digestive system: Review of selected updates on
neuroendocrine neoplasms, appendiceal tumors, and molecular
testing. Arch Pathol Lab Med. 145:664–677. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo LW, Shi CL, Huang HY, Wang L, Yue XP,
Liu SZ, Li J, Su K, Dai M, Sun XB and Shi JF: Economic burden of
esophageal cancer in China from 1996 to 2015: A systematic review.
Zhonghua Liu Xing Bing Xue Za Zhi. 38:102–109. 2017.(In Chinese).
PubMed/NCBI
|
|
4
|
Klimeck L, Heisser T, Hoffmeister M and
Brenner H: Colorectal cancer: A health and economic problem. Best
Pract Res Clin Gastroenterol. 66:1018392023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hojman P, Gehl J, Christensen JF and
Pedersen BK: Molecular mechanisms linking exercise to cancer
prevention and treatment. Cell Metab. 27:10–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu W, Li B, Xu M, Yang T and Hao X:
Traditional Chinese medicine for precancerous lesions of gastric
cancer: A review. Biomed Pharmacother. 146:1125422022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Qiu H, Li C, Cai P and Qi F: The
positive role of traditional Chinese medicine as an adjunctive
therapy for cancer. Biosci Trends. 15:283–298. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Halbrook CJ, Lyssiotis CA, Pasca di
Magliano M and Maitra A: Pancreatic cancer: Advances and
challenges. Cell. 186:1729–1754. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie YH, Chen YX and Fang JY: Comprehensive
review of targeted therapy for colorectal cancer. Signal Transduct
Target Ther. 5:222020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lorenzi L, Avila Cobos F, Decock A,
Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ,
Speleman F, Vandesompele J and Mestdagh P: Long noncoding RNA
expression profiling in cancer: Challenges and opportunities. Genes
Chromosomes Cancer. 58:191–199. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Dong X, Guo X, Li C, Fan Y, Liu
P, Yuan D, Ma X, Wang J, Zheng J, et al: LncRNA-BC069792 suppresses
tumor progression by targeting KCNQ4 in breast cancer. Mol Cancer.
22:412023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu
Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al: High expression of
ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is
associated with poor prognosis in neuroblastoma. Int J Oncol.
34:931–938. 2009.PubMed/NCBI
|
|
16
|
Ghafouri-Fard S, Khoshbakht T, Taheri M
and Shojaei S: A review on the role of small nucleolar RNA host
gene 6 long non-coding RNAs in the carcinogenic processes. Front
Cell Dev Biol. 9:7416842021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong CY, Tang R, Nan W, Zhou KS and Zhang
HH: Role of SNHG16 in human cancer. Clin Chim Acta. 503:175–180.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang M and Wei W: SNHG16: A novel long-non
coding RNA in human cancers. Onco Targets Ther. 12:11679–11690.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Zhou X, Tang Z, Fu L, Zou S and
Tang S: Knockdown of lncRNA SNHG16 attenuates the proliferation and
radioresistance of nasopharyngeal carcinoma cells by mediating
miR-31-5p/SFN axis. Radiat Res. 199:124–131. 2023.PubMed/NCBI
|
|
20
|
Cao X, Xu J and Yue D: LncRNA-SNHG16
predicts poor prognosis and promotes tumor proliferation through
epigenetically silencing p21 in bladder cancer. Cancer Gene Ther.
25:10–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang XS, Wang GX and Luo L: Long
non-coding RNA SNHG16 promotes cell growth and metastasis in
ovarian cancer. Eur Rev Med Pharmacol Sci. 22:616–622.
2018.PubMed/NCBI
|
|
22
|
Li S, Zhang S and Chen J: c-Myc induced
upregulation of long non-coding RNA SNHG16 enhances progression and
carcinogenesis in oral squamous cell carcinoma. Cancer Gene Ther.
26:400–410. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sealock T and Sharma S: Smoking Cessation.
StatPearls [Internet]. StatPearls Publishing; Treasure Island, FL:
2024
|
|
24
|
Yuan S, Chen J, Ruan X, Sun Y, Zhang K,
Wang X, Li X, Gill D, Burgess S, Giovannucci E and Larsson SC:
Smoking, alcohol consumption, and 24 gastrointestinal diseases:
Mendelian randomization analysis. Elife. 12:e840512023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
GBD 2019 Cancer Risk Factors
Collaborators, . The global burden of cancer attributable to risk
factors, 2010-19: A systematic analysis for the global burden of
disease study 2019. Lancet. 400:563–591. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marti-Aguado D, Clemente-Sanchez A and
Bataller R: Cigarette smoking and liver diseases. J Hepatol.
77:191–205. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baecker A, Liu X, La Vecchia C and Zhang
ZF: Worldwide incidence of hepatocellular carcinoma cases
attributable to major risk factors. Eur J Cancer Prev. 27:205–212.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cho WR, Wang CC, Tsai MJ, Lin CC, Yen YH,
Chen CH, Kuo YH, Yao CC, Hung CH, Huang PY, et al: Smoking as a
risk factor for very late recurrence in surgically resected
early-stage primary hepatocellular carcinoma. Clin Med Insights
Oncol. 18:117955492412282322024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Klein AP: Pancreatic cancer epidemiology:
Understanding the role of lifestyle and inherited risk factors. Nat
Rev Gastroenterol Hepatol. 18:493–502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lynch SM, Vrieling A, Lubin JH, Kraft P,
Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross
M, et al: Cigarette smoking and pancreatic cancer: A pooled
analysis from the pancreatic cancer cohort consortium. Am J
Epidemiol. 170:403–413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bosetti C, Lucenteforte E, Silverman DT,
Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, et
al: Cigarette smoking and pancreatic cancer: An analysis from the
international pancreatic cancer case-control consortium (Panc4).
Ann Oncol. 23:1880–1888. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghadirian P, Lynch HT and Krewski D:
Epidemiology of pancreatic cancer: An overview. Cancer Detect Prev.
27:87–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iodice S, Gandini S, Maisonneuve P and
Lowenfels AB: Tobacco and the risk of pancreatic cancer: A review
and meta-analysis. Langenbecks Arch Surg. 393:535–545. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weissman S, Takakura K, Eibl G, Pandol SJ
and Saruta M: The diverse involvement of cigarette smoking in
pancreatic cancer development and prognosis. Pancreas. 49:612–620.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Chen X, Hoffmeister M and Brenner H:
Associations of smoking with early- and late-onset colorectal
cancer. JNCI Cancer Spectr. 7:pkad0042023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han GH, Lu KJ, Wang P, Ye J, Ye YY and
Huang JX: LncRNA SNHG16 predicts poor prognosis in ESCC and
promotes cell proliferation and invasion by regulating
Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci.
22:3795–3803. 2018.PubMed/NCBI
|
|
37
|
Han W, Du X, Liu M, Wang J, Sun L and Li
Y: Increased expression of long non-coding RNA SNHG16 correlates
with tumor progression and poor prognosis in non-small cell lung
cancer. Int J Biol Macromol. 121:270–278. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Lu Y and Chen Y: Long non-coding RNA
SNHG16 affects cell proliferation and predicts a poor prognosis in
patients with colorectal cancer via sponging miR-200a-3p. Biosci
Rep. 39:BSR201824982019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gheliji T, Oskooei VK, Ashrafi Hafez A,
Taheri M and Ghafouri-Fard S: Evaluation of expression of vitamin D
receptor related lncRNAs in lung cancer. Noncoding RNA Res.
5:83–87. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiao R, Jiang W, Wei X, Zhang M, Zhao S
and Huang G: Clinicopathological significance and prognosis of long
noncoding RNA SNHG16 expression in human cancers: A meta-analysis.
BMC Cancer. 20:6622020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou L, Zhang Y, Jin J and Gu X:
Correlation between lncRNA SNHG16 gene polymorphism and its
interaction with environmental factors and susceptibility to
colorectal cancer. Medicine (Baltimore). 99:e233722020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Uhlenhopp DJ, Then EO, Sunkara T and
Gaduputi V: Epidemiology of esophageal cancer: Update in global
trends, etiology and risk factors. Clin J Gastroenterol.
13:1010–1021. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McGee EE, Jackson SS, Petrick JL, Van Dyke
AL, Adami HO, Albanes D, Andreotti G, Beane-Freeman LE, Berrington
de Gonzalez A, Buring JE, et al: Smoking, alcohol, and biliary
tract cancer risk: A pooling project of 26 prospective studies. J
Natl Cancer Inst. 111:1263–1278. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wood LD, Canto MI, Jaffee EM and Simeone
DM: Pancreatic cancer: Pathogenesis, screening, diagnosis, and
treatment. Gastroenterology. 163:386–402.e1. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Laszkowska M, Rodriguez S, Kim J and Hur
C: Heavy alcohol use is associated with gastric cancer: Analysis of
the national health and nutrition examination survey from 1999 to
2010. Am J Gastroenterol. 116:1083–1086. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
McNabb S, Harrison TA, Albanes D, Berndt
SI, Brenner H, Caan BJ, Campbell PT, Cao Y, Chang-Claude J, Chan A,
et al: Meta-analysis of 16 studies of the association of alcohol
with colorectal cancer. Int J Cancer. 146:861–873. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sheikh M, Roshandel G, McCormack V and
Malekzadeh R: Current status and future prospects for esophageal
cancer. Cancers (Basel). 15:7652023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Larsson SC, Carter P, Kar S, Vithayathil
M, Mason AM, Michaëlsson K and Burgess S: Smoking, alcohol
consumption, and cancer: A mendelian randomisation study in UK
Biobank and international genetic consortia participants. PLoS Med.
17:e10031782020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dong J and Thrift AP: Alcohol, smoking and
risk of oesophago-gastric cancer. Best Pract Res Clin
Gastroenterol. 31:509–517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Friedenreich CM, Ryder-Burbidge C and
McNeil J: Physical activity, obesity and sedentary behavior in
cancer etiology: Epidemiologic evidence and biologic mechanisms.
Mol Oncol. 15:790–800. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Moore SC, Lee IM, Weiderpass E, Campbell
PT, Sampson JN, Kitahara CM, Keadle SK, Arem H, Berrington de
Gonzalez A, Hartge P, et al: Association of leisure-time physical
activity with risk of 26 types of cancer in 1.44 million adults.
JAMA Intern Med. 176:816–825. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Su J, Jiang Y, Fan X, Tao R, Wu M, Lu Y,
Hua Y, Jin J, Guo Y, Lv J, et al: Association between physical
activity and cancer risk among Chinese adults: A 10-year
prospective study. Int J Behav Nutr Phys Act. 19:1502022.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kasvis P and Kilgour RD: Diet and exercise
interventions in patients with pancreatic cancer: A scoping review.
Pancreas. 50:657–666. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xie F, You Y, Huang J, Guan C, Chen Z,
Fang M, Yao F and Han J: Association between physical activity and
digestive-system cancer: An updated systematic review and
meta-analysis. J Sport Health Sci. 10:4–13. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Garrett WS: Cancer and the microbiota.
Science. 348:80–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nasrollahzadeh D, Malekzadeh R, Ploner A,
Shakeri R, Sotoudeh M, Fahimi S, Nasseri-Moghaddam S, Kamangar F,
Abnet CC, Winckler B, et al: Variations of gastric corpus
microbiota are associated with early esophageal squamous cell
carcinoma and squamous dysplasia. Sci Rep. 5:88202015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ponvilawan B, Rittiphairoj T, Charoenngam
N, Rujirachun P, Wattanachayakul P, Tornsatitkul S and Ungprasert
P: Association between chronic hepatitis C virus infection and
esophageal cancer: A systematic review and meta-analysis. J Clin
Gastroenterol. 56:55–63. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chidambaranathan-Reghupaty S, Fisher PB
and Sarkar D: Hepatocellular carcinoma (HCC): Epidemiology,
etiology and molecular classification. Adv Cancer Res. 149:1–61.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Singh AK, Kumar R and Pandey AK:
Hepatocellular carcinoma: Causes, mechanism of progression and
biomarkers. Curr Chem Genom Transl Med. 12:9–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga
Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, et
al: Association of Fusobacterium species in pancreatic
cancer tissues with molecular features and prognosis. Oncotarget.
6:7209–7220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fan X, Alekseyenko AV, Wu J, Peters BA,
Jacobs EJ, Gapstur SM, Purdue MP, Abnet CC, Stolzenberg-Solomon R,
Miller G, et al: Human oral microbiome and prospective risk for
pancreatic cancer: A population-based nested case-control study.
Gut. 67:120–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang YC: Medicinal plant activity on
Helicobacter pylori related diseases. World J Gastroenterol.
20:10368–10382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ailloud F, Didelot X, Woltemate S,
Pfaffinger G, Overmann J, Bader RC, Schulz C, Malfertheiner P and
Suerbaum S: Within-host evolution of Helicobacter pylori
shaped by niche-specific adaptation, intragastric migrations and
selective sweeps. Nat Commun. 10:22732019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Espinoza JL, Matsumoto A, Tanaka H and
Matsumura I: Gastric microbiota: An emerging player in
Helicobacter pylori-induced gastric malignancies. Cancer
Lett. 414:147–152. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Baj J, Korona-Glowniak I, Forma A, Maani
A, Sitarz E, Rahnama-Hezavah M, Radzikowska E and Portincasa P:
Mechanisms of the epithelial-mesenchymal transition and tumor
microenvironment in Helicobacter pylori-induced gastric
cancer. Cells. 9:10552020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Xia R, Zhang B, Wang X and Jia Q:
Pathogenic interactions between Helicobacter pylori adhesion
protein HopQ and human cell surface adhesion molecules CEACAMs in
gastric epithelial cells. Iran J Basic Med Sci. 22:710–715.
2019.PubMed/NCBI
|
|
67
|
Roesler BM, Rabelo-Gonçalves EMA and
Zeitune JMR: Virulence factors of Helicobacter pylori: A
review. Clin Med Insights Gastroenterol. 7:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sasaki S, Nishikawa J, Sakai K, Iizasa H,
Yoshiyama H, Yanagihara M, Shuto T, Shimokuri K, Kanda T, Suehiro
Y, et al: EBV-associated gastric cancer evades T-cell immunity by
PD-1/PD-L1 interactions. Gastric Cancer. 22:486–496. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Cuevas-Ramos G, Petit CR, Marcq I, Boury
M, Oswald E and Nougayrède JP: Escherichia coli induces DNA
damage in vivo and triggers genomic instability in mammalian cells.
Proc Natl Acad Sci USA. 107:11537–11542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Flemer B, Warren RD, Barrett MP, Cisek K,
Das A, Jeffery IB, Hurley E, O'Riordain M, Shanahan F and O'Toole
PW: The oral microbiota in colorectal cancer is distinctive and
predictive. Gut. 67:1454–1463. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhong JH, Xiang X, Wang YY, Liu X, Qi LN,
Luo CP, Wei WE, You XM, Ma L, Xiang BD and Li LQ: The lncRNA SNHG16
affects prognosis in hepatocellular carcinoma by regulating p62
expression. J Cell Physiol. 235:1090–1102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lin Q, Zheng H, Xu J, Zhang F and Pan H:
LncRNA SNHG16 aggravates tumorigenesis and development of
hepatocellular carcinoma by sponging miR-4500 and targeting STAT3.
J Cell Biochem. 120:11604–11615. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen H, Li M and Huang P: LncRNA SNHG16
promotes hepatocellular carcinoma proliferation, migration and
invasion by regulating miR-186 expression. J Cancer. 10:3571–3581.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ye J, Zhang R, Du X, Chai W and Zhou Q:
Long noncoding RNA SNHG16 induces sorafenib resistance in
hepatocellular carcinoma cells through sponging miR-140-5p. Onco
Targets Ther. 12:415–422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hu YL, Feng Y, Chen YY, Liu JZ, Su Y, Li
P, Huang H, Mao QS and Xue WJ: SNHG16/miR-605-3p/TRAF6/NF-κB
feedback loop regulates hepatocellular carcinoma metastasis. J Cell
Mol Med. 24:7637–7651. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Liu Q, Gao P, Li Q, Xu C, Qu K and Zhang
J: Long non-coding RNA SNHG16 as a potential biomarker in
hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore).
100:e271782021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Teng Y, Li M, Tao X, Huang Y, Ding X, Xu
D, Fan Y and Shen Z: Cryptococcosis inhibits the immune response of
dendritic cells through the snhg1-miR-145a-3p-Bcl2 axis. Exp Clin
Transplant. 21:441–450. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sun W, Zhang X, He X, Zhang J, Wang X, Lin
W, Wang X and Wu X: Long non-coding RNA SNHG16 silencing inhibits
proliferation and inflammation in Mycobacterium
tuberculosis-infected macrophages by targeting miR-140-5p
expression. Infect Genet Evol. 103:1053252022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Allen C, Her S and Jaffray DA:
Radiotherapy for cancer: Present and future. Adv Drug Deliv Rev.
109:1–2. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Nobel TB, Barbetta A, Hsu M, Tan KS,
Pinchinat T, Schlottmann F, Bains MS, Ku GY, Wu AJ, Patti MG, et
al: Outcomes of radiation-associated esophageal squamous cell
carcinoma: The MSKCC experience. J Gastrointest Surg. 23:11–22.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Thierry-Chef I, Cardis E, Damilakis J,
Frija GA, Hierath M and Hoeschen C: Medical applications of
ionizing radiation and radiation protection for European patients,
population and environment. EPJ Nuclear Sci Technol. 8:442022.
View Article : Google Scholar
|
|
82
|
Goerlitz DS, Blancato J, Ramesh A, Islam
M, Graham GT, Revina V, Kallakury B, Zeck J, Kirillova E and
Loffredo CA: Somatic mutation signatures in primary liver tumors of
workers exposed to ionizing radiation. Sci Rep. 9:181992019.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Dores GM, Curtis RE, van Leeuwen FE,
Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH,
Hodgson DC, et al: Pancreatic cancer risk after treatment of
Hodgkin lymphoma. Ann Oncol. 25:2073–2079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yusefi AR, Bagheri Lankarani K, Bastani P,
Radinmanesh M and Kavosi Z: Risk factors for gastric cancer: A
systematic review. Asian Pac J Cancer Prev. 19:591–603.
2018.PubMed/NCBI
|
|
85
|
Kreuzer M, Straif K, Marsh JW, Dufey F,
Grosche B, Nosske D and Sogl M: Occupational dust and radiation
exposure and mortality from stomach cancer among German uranium
miners, 1946–2003. Occup Environ Med. 69:217–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Albert JM: Radiation risk from CT:
Implications for cancer screening. AJR Am J Roentgenol.
201:W81–W87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Sun Y, Zhang T, Wu W, Zhao D, Zhang N, Cui
Y, Liu Y, Gu J, Lu P, Xue F, et al: Risk factors associated with
precancerous lesions of esophageal squamous cell carcinoma: A
screening study in a high risk Chinese population. J Cancer.
10:3284–3290. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhang L, Wan X, Shi R, Gong P and Si Y:
Comparing spatial patterns of 11 common cancers in Mainland China.
BMC Public Health. 22:15512022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yang CY, Tsai SS and Chiu HF: Nitrate in
drinking water and risk of death from pancreatic cancer in Taiwan.
J Toxicol Environ Health A. 72:397–401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Picetti R, Deeney M, Pastorino S, Miller
MR, Shah A, Leon DA, Dangour AD and Green R: Nitrate and nitrite
contamination in drinking water and cancer risk: A systematic
review with meta-analysis. Environ Res. 210:1129882022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Nasseri Maleki G, Bayati Khatibi M,
Khamnian Z, Jalali Z, Dastgiri S and Ghodrati Aroogh H: Association
between nitrate concentration in drinking water and rate of
colorectal cancer: A case study in northwestern Iran. Int J Environ
Health Res. 32:1791–1800. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lee W, Kim J, Lim SS, Kim Y, Ahn YS and
Yoon JH: External airborne-agent exposure increase risk of
digestive tract cancer. Sci Rep. 10:86172020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Tsai SS, Hsu CT and Yang C: Risk of death
from liver cancer in relation to long-term exposure to fine
particulate air pollution in Taiwan. J Toxicol Environ Health A.
86:135–143. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Pritchett N, Spangler EC, Gray GM,
Livinski AA, Sampson JN, Dawsey SM and Jones RR: Exposure to
outdoor particulate matter air pollution and risk of
gastrointestinal cancers in adults: A systematic review and
meta-analysis of epidemiologic evidence. Environ Health Perspect.
130:360012022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Taheri M, Rad LM, Hussen BM, Nicknafs F,
Sayad A and Ghafouri-Fard S: Evaluation of expression of
VDR-associated lncRNAs in COVID-19 patients. BMC Infect Dis.
21:5882021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zhang S, Chen J, Li B, Cai X, Wang K, Tan
Z, Zheng Y and Liu Q: Family history of cancer is a prognostic
factor for better survival in operable esophageal squamous cell
carcinoma: A propensity score matching analysis. Front Oncol.
12:9459372022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yang Y, Wu QJ, Xie L, Chow WH, Rothman N,
Li HL, Gao YT, Zheng W, Shu XO and Xiang YB: Prospective cohort
studies of association between family history of liver cancer and
risk of liver cancer. Int J Cancer. 135:1605–1614. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Abe K, Kitago M, Kitagawa Y and Hirasawa
A: Hereditary pancreatic cancer. Int J Clin Oncol. 26:1784–1792.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC,
Park B and Joo J: Family history of gastric cancer and
Helicobacter pylori treatment. N Engl J Med. 382:427–436.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Sninsky JA, Shore BM, Lupu GV and Crockett
SD: Risk factors for colorectal polyps and cancer. Gastrointest
Endosc Clin N Am. 32:195–213. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Chen T, Cheng H, Chen X, Yuan Z, Yang X,
Zhuang M, Lu M, Jin L and Ye W: Family history of esophageal cancer
increases the risk of esophageal squamous cell carcinoma. Sci Rep.
5:160382015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Setia N, Clark JW, Duda DG, Hong TS, Kwak
EL, Mullen JT and Lauwers GY: Familial gastric cancers. Oncologist.
20:1365–1377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chan JA, Meyerhardt JA, Niedzwiecki D,
Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R,
Hantel A, et al: Association of family history with cancer
recurrence and survival among patients with stage III colon cancer.
JAMA. 299:2515–2523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Han MA, Oh MG, Choi IJ, Park SR, Ryu KW,
Nam BH, Cho SJ, Kim CG, Lee JH and Kim YW: Association of family
history with cancer recurrence and survival in patients with
gastric cancer. J Clin Oncol. 30:701–708. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Su Z, Zou GR, Mao YP, OuYang PY, Cao XL,
Xie FY and Li Q: Prognostic impact of family history of cancer in
Southern Chinese patients with esophageal squamous cell cancer. J
Cancer. 10:1349–1357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Dai WC, Fan ST, Cheung TT, Chok KS, Chan
AC, Tsang SH, Poon RT and Lo CM: The impact of family history of
hepatocellular carcinoma on its patients' survival. Hepatobiliary
Pancreat Dis Int. 11:160–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Hamada T, Yuan C, Yurgelun MB, Perez K,
Khalaf N, Morales-Oyarvide V, Babic A, Nowak JA, Rubinson DA,
Giannakis M, et al: Family history of cancer, Ashkenazi Jewish
ancestry, and pancreatic cancer risk. Br J Cancer. 120:848–854.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Chen Y, Tong Y, Yang C, Gan Y, Sun H, Bi
H, Cao S, Yin X and Lu Z: Consumption of hot beverages and foods
and the risk of esophageal cancer: A meta-analysis of observational
studies. BMC Cancer. 15:4492015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Keszei AP, Goldbohm RA, Schouten LJ,
Jakszyn P and van den Brandt PA: Dietary N-nitroso compounds,
endogenous nitrosation, and the risk of esophageal and gastric
cancer subtypes in the Netherlands cohort study. Am J Clin Nutr.
97:135–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ibiebele TI, Hughes MC, Whiteman DC and
Webb PM; Australian Cancer Study, : Dietary patterns and risk of
oesophageal cancers: A population-based case-control study. Br J
Nutr. 107:1207–1216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Kim J, Cho YA, Choi WJ and Jeong SH:
Gene-diet interactions in gastric cancer risk: A systematic review.
World J Gastroenterol. 20:9600–9610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Cheng YK, Yao SM, Xu YR and Niu RG:
Life-style habits in a high-risk area for upper gastrointestinal
cancers: A population-based study from Shanxi, China. Asian Pac J
Cancer Prev. 17:4301–4306. 2016.PubMed/NCBI
|
|
113
|
Berretta M, Lleshi A, Fisichella R,
Berretta S, Basile F, Li Volti G, Bolognese A, Biondi A, De Paoli
P, Tirelli U and Cappellani A: The role of nutrition in the
development of esophageal cancer: What do we know? Front Biosci
(Elite Ed). 4:351–357. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
114
|
Zhang Z and Zhang X: Salt taste
preference, sodium intake and gastric cancer in China. Asian Pac J
Cancer Prev. 12:1207–1210. 2011.PubMed/NCBI
|
|
115
|
Thanikachalam K and Khan G: Colorectal
cancer and nutrition. Nutrients. 11:1642019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Song M, Garrett WS and Chan AT: Nutrients,
foods, and colorectal cancer prevention. Gastroenterology.
148:1244–1260.e16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Rosato V, Bosetti C, Levi F, Polesel J,
Zucchetto A, Negri E and La Vecchia C: Risk factors for young-onset
colorectal cancer. Cancer Causes Control. 24:335–341. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Murata M: Inflammation and cancer. Environ
Health Prev Med. 23:502018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Ohnishi S, Ma N, Thanan R, Pinlaor S,
Hammam O, Murata M and Kawanishi S: DNA damage in
inflammation-related carcinogenesis and cancer stem cells. Oxid Med
Cell Longev. 2013:3870142013. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Wang RH: From reflux esophagitis to
Barrett's esophagus and esophageal adenocarcinoma. World J
Gastroenterol. 21:5210–5219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Ioannou GN: Epidemiology and
risk-stratification of NAFLD-associated HCC. J Hepatol.
75:1476–1484. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Powell EE, Wong VW and Rinella M:
Non-alcoholic fatty liver disease. Lancet. 397:2212–2224. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Pouwels S, Sakran N, Graham Y, Leal A,
Pintar T, Yang W, Kassir R, Singhal R, Mahawar K and Ramnarain D:
Non-alcoholic fatty liver disease (NAFLD): A review of
pathophysiology, clinical management and effects of weight loss.
BMC Endocr Disord. 22:632022. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Duell EJ, Lucenteforte E, Olson SH, Bracci
PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, et
al: Pancreatitis and pancreatic cancer risk: A pooled analysis in
the international pancreatic cancer case-control consortium
(PanC4). Ann Oncol. 23:2964–2970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Sipponen P and Maaroos HI: Chronic
gastritis. Scand J Gastroenterol. 50:657–667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Tempera PJ, Michael M, Tageldin O and
Hasak S: Gastric cancer due to chronic H. pylori infection:
What we know and where we are going. Diseases. 10:572022.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Kim J and Lee HK: Potential role of the
gut microbiome in colorectal cancer progression. Front Immunol.
12:8076482022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Xu B, Zhou X, Li X, Liu C and Yang C:
Diabetes mellitus carries a risk of esophageal cancer: A
meta-analysis. Medicine (Baltimore). 96:e79442017. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Li M, Park JY, Sheikh M, Kayamba V, Rumgay
H, Jenab M, Narh CT, Abedi-Ardekani B, Morgan E, de Martel C, et
al: Population-based investigation of common and deviating patterns
of gastric cancer and oesophageal cancer incidence across
populations and time. Gut. 72:846–854. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Chari ST, Leibson CL, Rabe KG, Ransom J,
de Andrade M and Petersen GM: Probability of pancreatic cancer
following diabetes: A population-based study. Gastroenterology.
129:504–511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Lim JH, Shin CM, Han KD, Lee SW, Jin EH,
Choi YJ, Yoon H, Park YS, Kim N and Lee DH: Association between the
persistence of obesity and the risk of gastric cancer: A nationwide
population-based study. Cancer Res Treat. 54:199–207. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Guo J, Liu C, Pan J and Yang J:
Relationship between diabetes and risk of gastric cancer: A
systematic review and meta-analysis of cohort studies. Diabetes Res
Clin Pract. 187:1098662022. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Soltani G, Poursheikhani A, Yassi M,
Hayatbakhsh A, Kerachian M and Kerachian MA: Obesity, diabetes and
the risk of colorectal adenoma and cancer. BMC Endocr Disord.
19:1132019. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Plaz Torres MC, Jaffe A, Perry R,
Marabotto E, Strazzabosco M and Giannini EG: Diabetes medications
and risk of HCC. Hepatology. 76:1880–1897. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Guo Z, Zhang J, Fan L, Liu J, Yu H, Li X
and Sun G: Long noncoding RNA (lncRNA) small nucleolar RNA host
gene 16 (SNHG16) predicts poor prognosis and sorafenib resistance
in hepatocellular carcinoma. Med Sci Monit. 25:2079–2086. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Zhang QJ, Li DZ, Lin BY, Geng L, Yang Z
and Zheng SS: SNHG16 promotes hepatocellular carcinoma development
via activating ECM receptor interaction pathway. Hepatobiliary
Pancreat Dis Int. 21:41–49. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Zhang C, Huang Q and He F: Correlation of
small nucleolar RNA host gene 16 with acute respiratory distress
syndrome occurrence and prognosis in sepsis patients. J Clin Lab
Anal. 36:e245162022. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Sun J, Xin K, Leng C and Ge J:
Down-regulation of SNHG16 alleviates the acute lung injury in
sepsis rats through miR-128-3p/HMGB3 axis. BMC Pulm Med.
21:1912021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Xia L, Zhu G, Huang H, He Y and Liu X:
LncRNA small nucleolar RNA host gene 16 (SNHG16) silencing protects
lipopolysaccharide (LPS)-induced cell injury in human lung
fibroblasts WI-38 through acting as miR-141-3p sponge. Biosci
Biotechnol Biochem. 85:1077–1087. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Zhou Z, Zhu Y, Gao G and Zhang Y: Long
noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate
LPS-induced WI-38 cell apoptosis and inflammation in acute
pneumonia. Life Sci. 228:189–197. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Xie C, Zhu B, Gu J and Sun M: The
correlation of lncRNA SNHG16 with inflammatory cytokines, adhesion
molecules, disease severity, and prognosis in acute ischemic stroke
patients. J Clin Lab Anal. 36:e244392022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Zhao Y, Wang H, Tang Y, Wang J, Wu X, He
Z, He Y and Tang Z: SNHG16/miR-205/HDAC5 is involved in the
progression of renal fibrosis. J Biochem Mol Toxicol.
38:e236172024. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Luo J: KRAS mutation in pancreatic cancer.
Semin Oncol. 48:10–18. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Mei ZB, Duan CY, Li CB, Cui L and Ogino S:
Prognostic role of tumor PIK3CA mutation in colorectal cancer: A
systematic review and meta-analysis. Ann Oncol. 27:1836–1848. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Cox AD, Fesik SW, Kimmelman AC, Luo J and
Der CJ: Drugging the undruggable RAS: Mission possible? Nat Rev
Drug Discov. 13:828–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Busuttil RA, Zapparoli GV, Haupt S,
Fennell C, Wong SQ, Pang JM, Takeno EA, Mitchell C, Di Costanzo N,
Fox S, et al: Role of p53 in the progression of gastric cancer.
Oncotarget. 5:12016–12026. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Li Y, Wu J, Li E, Xiao Z, Lei J, Zhou F,
Yin X, Hu D, Mao Y, Wu L and Wenjun L: TP53 mutation detected in
circulating exosomal DNA is associated with prognosis of patients
with hepatocellular carcinoma. Cancer Biol Ther. 23:439–445. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Wang W, Shao F, Yang X, Wang J, Zhu R,
Yang Y, Zhao G, Guo D, Sun Y, Wang J, et al: METTL3 promotes tumour
development by decreasing APC expression mediated by APC mRNA
N(6)-methyladenosine-dependent YTHDF binding. Nat Commun.
12:38032021. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zeineldin M and Neufeld KL: Understanding
phenotypic variation in rodent models with germline Apc mutations.
Cancer Res. 73:2389–2399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Cui R, Kamatani Y, Takahashi A, Usami M,
Hosono N, Kawaguchi T, Tsunoda T, Kamatani N, Kubo M, Nakamura Y
and Matsuda K: Functional variants in ADH1B and ALDH2 coupled with
alcohol and smoking synergistically enhance esophageal cancer risk.
Gastroenterology. 137:1768–1775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Ilango S, Paital B, Jayachandran P, Padma
PR and Nirmaladevi R: Epigenetic alterations in cancer. Front
Biosci (Landmark Ed). 25:1058–1109. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Zhang K, Chen J, Song H and Chen LB:
SNHG16/miR-140-5p axis promotes esophagus cancer cell
proliferation, migration and EMT formation through regulating ZEB1.
Oncotarget. 9:1028–1040. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Zhang L, Liang H, Zhang J, Yang Y, Ling X
and Jiang H: Long non-coding RNA SNHG16 facilitates esophageal
cancer cell proliferation and self-renewal through the
microRNA-802/PTCH1 axis. Curr Med Chem. 29:6084–6099. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Ren L, Fang X, Shrestha SM, Ji Q, Ye H,
Liang Y, Liu Y, Feng Y, Dong J and Shi R: LncRNA SNHG16 promotes
development of oesophageal squamous cell carcinoma by interacting
with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett.
27:892022. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Xie X, Xu X, Sun C and Yu Z: Long
intergenic noncoding RNA SNHG16 interacts with miR-195 to promote
proliferation, invasion and tumorigenesis in hepatocellular
carcinoma. Exp Cell Res. 383:1115012019. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Li S, Qi Y, Huang Y, Guo Y, Huang T and
Jia L: Exosome-derived SNHG16 sponging miR-4500 activates HUVEC
angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in
hepatocellular carcinoma. J Physiol Biochem. 77:667–682. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Li W, Xu W, Song JS, Wu T and Wang WX:
LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19
axis in hepatocellular carcinoma. Neoplasma. 66:397–404. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Li S, Peng F, Ning Y, Jiang P, Peng J,
Ding X, Zhang J, Jiang T and Xiang S: SNHG16 as the miRNA let-7b-5p
sponge facilitates the G2/M and epithelial-mesenchymal transition
by regulating CDC25B and HMGA2 expression in hepatocellular
carcinoma. J Cell Biochem. 121:2543–2558. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Jing Z, Ye X, Ma X, Hu X, Yang W, Shi J,
Chen G and Gong L: SNGH16 regulates cell autophagy to promote
sorafenib resistance through suppressing miR-23b-3p via sponging
EGR1 in hepatocellular carcinoma. Cancer Med. 9:4324–4338. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Xu Y, Luan G, Li Z, Liu Z, Qin G and Chu
Y: Tumour-derived exosomal lncRNA SNHG16 induces telocytes to
promote metastasis of hepatocellular carcinoma via the
miR-942-3p/MMP9 axis. Cell Oncol (Dordr). 46:251–264.
2023.PubMed/NCBI
|
|
161
|
Zhang J and Lou W: A key mRNA-miRNA-lncRNA
competing endogenous RNA triple sub-network linked to diagnosis and
prognosis of hepatocellular carcinoma. Front Oncol. 10:3402020.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Chen S, Zhao Z, Wang X, Zhang Q, Lyu L and
Tang B: The predictive competing endogenous RNA regulatory networks
and potential prognostic and immunological roles of cyclin A2 in
pan-cancer analysis. Front Mol Biosci. 9:8095092022. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Shao X, Zhu J, Shi Y, Fang H, Chen J,
Zhang Y, Wang J, Jian H, Lan S, Jiang F, et al: Upregulated UBE4B
expression correlates with poor prognosis and tumor immune
infiltration in hepatocellular carcinoma. Aging (Albany NY).
14:9632–9646. 2022.PubMed/NCBI
|
|
164
|
Lou W, Wang W, Chen J, Wang S and Huang Y:
ncRNAs-mediated high expression of SEMA3F correlates with poor
prognosis and tumor immune infiltration of hepatocellular
carcinoma. Mol Ther Nucleic Acids. 24:845–855. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Xu F, Zha G, Wu Y, Cai W and Ao J:
Overexpressing lncRNA SNHG16 inhibited HCC proliferation and
chemoresistance by functionally sponging hsa-miR-93. Onco Targets
Ther. 11:8855–8863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Xu H, Miao X, Li X, Chen H, Zhang B and
Zhou W: LncRNA SNHG16 contributes to tumor progression via the
miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma. Cancer Cell
Int. 21:512021. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Yu Y, Zou YF, Hong RQ, Chen WJ, Chen L,
Chen WQ, Wang HP and Yu Y: Long non-coding RNA SNHG16 decreased
SMAD4 to induce gemcitabine resistance in pancreatic cancer via
EZH2-mediated epigenetic modification. Kaohsiung J Med Sci.
38:981–991. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yu Y, Dong JT, He B, Zou YF, Li XS, Xi CH
and Yu Y: LncRNA SNHG16 induces the SREBP2 to promote lipogenesis
and enhance the progression of pancreatic cancer. Future Oncol.
15:3831–3844. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Ding Y, Gao S, Zheng J and Chen X:
Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu
through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
Cancer Metab. 10:202022. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Lian D, Amin B, Du D and Yan W: Enhanced
expression of the long non-coding RNA SNHG16 contributes to gastric
cancer progression and metastasis. Cancer Biomark. 21:151–160.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Zhao JJ, Liu JJ, Zhang YY, Xia Y, Du H,
Yan ZQ, Zhou CH, Xia WS, Zellmer L, Liao DJ, et al: SNHG16 lncRNAs
are overexpressed and may be oncogenic in human gastric cancer by
regulating cell cycle progression. Neoplasma. 69:49–58. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Zhou C, Zhao J, Liu J, Wei S, Xia Y, Xia
W, Bi Y, Yan Z and Huang H: LncRNA SNHG16 promotes
epithelial-mesenchymal transition via down-regulation of DKK3 in
gastric cancer. Cancer Biomark. 26:393–401. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Yang Z, Pu M, Dong X, Yang H, Chang W, Liu
T and Zhang X: CTCF-activated SNHG16 facilitates gastrointestinal
stromal tumor by targeting miR-128-3p/CASC3 axis. Exp Cell Res.
417:1131312022. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Wang X, Kan J, Han J, Zhang W, Bai L and
Wu H: LncRNA SNHG16 functions as an oncogene by sponging MiR-135a
and promotes JAK2/STAT3 signal pathway in gastric cancer. J Cancer.
10:1013–1022. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Zhou W, Zhang S, Li HB, Cai Z, Tang S,
Chen LX, Lang JY, Chen Z and Chen XL: Development of prognostic
indicator based on autophagy-related lncRNA analysis in colon
adenocarcinoma. Biomed Res Int. 2020:98079182020. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Chen ZY, Wang XY, Yang YM, Wu MH, Yang L,
Jiang DT, Cai H and Peng Y: LncRNA SNHG16 promotes colorectal
cancer cell proliferation, migration, and epithelial-mesenchymal
transition through miR-124-3p/MCP-1. Gene Ther. 29:193–205. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Tan P, Xu M, Nie J, Qin J, Liu X, Sun H,
Wang S and Pan Y: LncRNA SNHG16 promotes colorectal cancer
proliferation by regulating ABCB1 expression through sponging
miR-214-3p. J Biomed Res. 36:231–241. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
He X, Ma J, Zhang M, Cui J and Yang H:
Long non-coding RNA SNHG16 activates USP22 expression to promote
colorectal cancer progression by sponging miR-132-3p. Onco Targets
Ther. 13:4283–4294. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Ke D and Wang Q, Ke S, Zou L and Wang Q:
Long-non coding RNA SNHG16 supports colon cancer cell growth by
modulating miR-302a-3p/AKT axis. Pathol Oncol Res. 26:1605–1613.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Huang E, Ma T, Zhou J, Ma N, Yang W, Liu
C, Hou Z, Chen S, Zong Z, Zeng B, et al: A novel
senescence-associated LncRNA signature predicts the prognosis and
tumor microenvironment of patients with colorectal cancer: A
bioinformatics analysis. J Gastrointest Oncol. 13:1842–1863. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Duan L, Xia Y, Li C, Lan N and Hou X:
Identification of autophagy-related LncRNA to predict the prognosis
of colorectal cancer. Front Genet. 13:9069002022. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Christensen LL, True K, Hamilton MP,
Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen
JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in
colorectal cancer and affects genes involved in lipid metabolism.
Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Xiang Z, Huang G, Wu H, He Q, Yang C, Dou
R, Liu Q, Song J, Fang Y, Wang S and Xiong B: SNHG16
upregulation-induced positive feedback loop with YAP1/TEAD1 complex
in colorectal cancer cell lines facilitates liver metastasis of
colorectal cancer by modulating CTCs epithelial-mesenchymal
transition. Int J Biol Sci. 18:5291–5308. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Wu T, Lei MS, Gao XZ, Xiong TG, Yang K,
Gong Q, Tang R, Tian YP and Fu XH: lncRNA SNHG16 mediates cell
proliferation and apoptosis in cholangiocarcinoma by directly
targeting miR-146a-5p/GATA6 axis. Biochem Genet. 59:1311–1325.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Dasari A, Shen C, Halperin D, Zhao B, Zhou
S, Xu Y, Shih T and Yao JC: Trends in the incidence, prevalence,
and survival outcomes in patients with neuroendocrine tumors in the
United States. JAMA Oncol. 3:1335–1342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
He W, Li Q, Lu Y, Ju D, Gu Y, Zhao K and
Dong C: Cancer treatment evolution from traditional methods to stem
cells and gene therapy. Curr Gene Ther. 22:368–385. 2022.
View Article : Google Scholar : PubMed/NCBI
|
